Two Sigma Advisers’s Acutus Medical Inc AFIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-167,700
Closed -$233K 2939
2022
Q1
$233K Sell
167,700
-34,200
-17% -$73.1K ﹤0.01% 2334
2021
Q4
$688K Buy
201,900
+121,600
+151% +$685K ﹤0.01% 1751
2021
Q3
$710K Buy
+80,300
New +$1.06M ﹤0.01% 1775
2021
Q2
Sell
-17,000
Closed -$227K 2755
2021
Q1
$227K Buy
+17,000
New +$383K ﹤0.01% 2322

Other funds holding AFIB

Two Sigma Advisers's AFIB Position: Q2 2022 in Review

Two Sigma Advisers sold out of Acutus Medical Inc (AFIB) in Q2 2022, closing a stake of 167,700 shares — an estimated $233K sold.

Two Sigma Advisers first reported a position in AFIB in Q1 2021 and held it in 4 quarters. The position peaked at $710K in Q3 2021. 47 funds tracked by Wall St. Rank hold AFIB as of Q2 2022.

  • Two Sigma Advisers reported no remaining Acutus Medical Inc position as of Q2 2022 after selling out during the quarter.
  • Two Sigma Advisers sold 167,700 Acutus Medical Inc shares in Q2 2022, an estimated $233K.
  • Two Sigma Advisers first reported a position in Acutus Medical Inc in Q1 2021 and held it in 4 quarters.
  • Two Sigma Advisers's Acutus Medical Inc position peaked at $710K in Q3 2021.
  • 47 funds tracked by Wall St. Rank held Acutus Medical Inc as of Q2 2022.

Based on Two Sigma Advisers's 13F filing for Q2 2022, filed 15 Aug 2022.